blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0383591

EP0383591 - Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention of fibrotic lesions [Right-click to bookmark this link]
Former [1990/34]Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention and treatment of fibrotic lesions
[2000/45]
StatusNo opposition filed within time limit
Status updated on  27.09.2002
Database last updated on 19.07.2024
Most recent event   Tooltip27.09.2002No opposition filed within time limitpublished on 13.11.2002  [2002/46]
Applicant(s)For all designated states
Yamauchi, Shitotomo
c/o KDL INC., Central Bldg. Ichibancho 22-1 Chiyoda
Tokyo 102 / JP
For all designated states
MARGOLIN, Solomon B.
6723 Desco Drive
Dallas, Texas 75225 / US
[N/P]
Former [1996/19]For all designated states
Yamauchi, Shitotomo
c/o KDL INC., Central Bldg. Ichibancho 22-1
Chiyoda, Tokyo 102 / JP
For all designated states
MARGOLIN, Solomon B.
6723 Desco Drive
Dallas, Texas 75225 / US
Former [1990/34]For all designated states
Yamauchi, Shitotomo
c/o KDL INC., Central Bldg. Ichibancho 22-1
Chiyoda, Tokyo 102 / JP
Inventor(s)01 / Margolin, Solmon B.
c/o.MARNAC Inc.,6723 Desco Drive
Dallas, Texas 75225 / US
 [2001/47]
Former [1990/34]01 / Margolin, Solmon B. c/o Timothy Medical Sciences
Company, Inc., 11, Lewis Road
Trumbull - Connecticut 06611 / US
Representative(s)Bannerman, David Gardner, et al
Withers & Rogers LLP
4 More London Riverside
London
SE1 2AU / GB
[N/P]
Former [1997/48]Bannerman, David Gardner, et al
Withers & Rogers 4 Dyer's Buildings Holborn
London, EC1N 2JT / GB
Former [1995/35]Baker, Colin John, et al
Withers & Rogers, 4 Dyer's Buildings, Holborn
London EC1N 2JT / GB
Former [1994/35]Arthur, Bryan Edward
Withers & Rogers 4 Dyers Buildings Holborn
London, EC1N 2JT / GB
Former [1990/34]Silveston, Judith
ABEL & IMRAY Northumberland House 303-306 High Holborn
London, WC1V 7LH / GB
Application number, filing date90301607.915.02.1990
[1990/34]
Priority number, dateJP1989003543615.02.1989         Original published format: JP 3543689
[1990/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0383591
Date:22.08.1990
Language:EN
[1990/34]
Type: A3 Search report 
No.:EP0383591
Date:15.01.1992
Language:EN
[1992/03]
Type: B1 Patent specification 
No.:EP0383591
Date:21.11.2001
Language:EN
[2001/47]
Search report(s)(Supplementary) European search report - dispatched on:EP26.11.1991
ClassificationIPC:A61K31/44
[1990/34]
CPC:
A61K31/4412 (EP); A61K31/44 (EP); A61P13/02 (EP);
A61P15/00 (EP); A61P17/12 (EP); A61P3/00 (EP);
A61P37/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP) (-)
Designated contracting statesBE,   DE,   ES,   FR,   GB,   IT [1990/34]
TitleGerman:Verwendung von 5-methyl-1-phenyl-2-(1H)-pyridon zur Vorbeugung fibrotischer Schädigungen[2000/45]
English:Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention of fibrotic lesions[2000/45]
French:Utilisation de la 5-méthyl-1-phényl-2-(1H)-pyridone pour la prévention des lésions fibrotiques[2000/45]
Former [1990/34]Verwendung von 5-methyl-1-phenyl-2-(1H)-pyridon zur Vorbeugung und Behandlung der fibrotischen Schädigungen
Former [1990/34]Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention and treatment of fibrotic lesions
Former [1990/34]Utilisation de la 5-méthyl-1-phényl-2-(1H)-pyridone pour la prévention et le traitement des lésions fibrotiques
Examination procedure02.03.1990Examination requested  [1990/34]
30.03.1994Despatch of a communication from the examining division (Time limit: M04)
08.08.1994Reply to a communication from the examining division
09.03.1995Despatch of a communication from the examining division (Time limit: M04)
16.06.1995Reply to a communication from the examining division
12.07.1995Despatch of a communication from the examining division (Time limit: M02)
13.07.1995Reply to a communication from the examining division
22.11.1995Despatch of a communication from the examining division (Time limit: M06)
22.05.1996Reply to a communication from the examining division
26.03.1998Despatch of a communication from the examining division (Time limit: M04)
10.07.1998Reply to a communication from the examining division
03.02.1999Despatch of a communication from the examining division (Time limit: M04)
07.06.1999Reply to a communication from the examining division
13.10.2000Despatch of communication of intention to grant (Approval: No)
28.03.2001Despatch of communication of intention to grant (Approval: later approval)
25.05.2001Communication of intention to grant the patent
24.08.2001Fee for grant paid
24.08.2001Fee for publishing/printing paid
Divisional application(s)EP01107235.2  / EP1138329
Opposition(s)22.08.2002No opposition filed within time limit [2002/46]
Fees paidRenewal fee
11.02.1992Renewal fee patent year 03
17.02.1993Renewal fee patent year 04
15.02.1994Renewal fee patent year 05
14.02.1995Renewal fee patent year 06
08.02.1996Renewal fee patent year 07
17.02.1997Renewal fee patent year 08
06.02.1998Renewal fee patent year 09
11.02.1999Renewal fee patent year 10
11.02.2000Renewal fee patent year 11
19.02.2001Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]US4042699  (GADEKAR SHREEKRISHNA M)
 [X]  - FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, FED. PROC., New Orleans, Louisiana, 15th - 23rd April 1982, vol. 41, no. 5, abstract no. 7480; S. MARGOLIN et al.: "Removal of interstitial Pulmonary fibrosis (asbestos-induced) by oral chemotherapy with pirfenidone"
 [A]  - DRUGS OF THE FUTURE, vol. 11, no. 6, June 1977, pages 396-397; P.J. ROBERTS et al.: "Pirfenidone"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.